President Trump just opened the door for drug prices to skyrocket. Without the implementation of these and similar plans focused on reducing costs, Medicare and Medicaid beneficiaries will continue to face high out-of-pocket expenses for prescription drugs and will have limited access to important - sometimes essential - prescriptions. We all know too many Americans already facing challenges paying for prescription drugs.